Ohio State offers the newest, minimally invasive treatments for all forms of heart valve disease

The Ohio State University Heart and Vascular Center’s Structural Heart Disease Program is a leader in providing patients with heart valve disease access to the newest and most advanced treatments.

Ohio State is one of only a handful of centers in Ohio offering transcatheter aortic valve replacement (TAVR) for aortic valve regurgitation or aortic valve stenosis. We are currently participating in a variety of clinical trials, evaluating groundbreaking therapies in patients with structural heart disease.

Our dedicated program for structural heart disease offers you access to the most advanced treatments and options for every condition. We have assembled a team of experts including interventional cardiologists, cardiac surgeons, dedicated nursing staff and other specialists, to ensure you receive the most comprehensive care available.

Our team can evaluate your condition and provide treatment options for you – whether this is your initial consultation or you are looking for a second opinion. Our advanced treatment options are giving new hope to patients who previously were not considered candidates for treatment due to advanced age or condition.

Advancing Care for Heart Valve Diseases at Ohio State

Transcatheter Aortic Valve Replacement

Minimally invasive treatment for severe aortic stenosis

How the TAVR Procedure Works

This video shows how the Transcatheter Aortic Valve Replacement (TAVR) procedure is performed.

Our Leaders

Our leaders


Scott Lilly, MD, PhD

Scott Lilly, MD, PhD, is an interventional cardiologist and co-director of the Ohio State Structural Heart Disease program. Dr. Lilly specializes in treating aortic valve disorders. 


Gregory Rushing, MD

Gregory Rushing, MD, is a cardiac surgeon and co-director of the Ohio State Structural Heart Disease program. Dr. Rushing specializes in aortic surgery and adult cardiac surgery.

Share this Page